The new Singapore subsidiary will support the delivery of mRNA vaccines and therapeutics in the country.
NASDAQ-listed Moderna Inc has announced its plans to establish a new subsidiary in Singapore, along with three other subsidiaries in Malaysia, Taiwan and Hong Kong on Feb 16.
The subsidiaries will build on Moderna’s existing presence in the region with offices in Japan, South Korea and Australia.
